David E. Nichols
update
| ← Previous revision | Revision as of 03:20, 27 April 2026 | ||
| Line 18: | Line 18: | ||
Previously the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology at [[Purdue University]], Nichols has worked in the field of [[psychoactive]] drugs since 1969. While still a graduate student, he patented the method that is used to make the optical [[isomers]] of [[psychedelic drug|psychedelic]] [[substituted amphetamine|amphetamine]]s. His contributions include the synthesis and reporting of [[escaline]], [[LSZ]], [[6-APB]], [[2C-I-NBOMe]] and other NBOMe variants ([[NBOMe-2C-B]], [[NBOMe-2C-C]], [[NBOMe-2C-D]]), and several others, as well as the coining of the term "[[entactogen]]". |
Previously the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology at [[Purdue University]], Nichols has worked in the field of [[psychoactive]] drugs since 1969. While still a graduate student, he patented the method that is used to make the optical [[isomers]] of [[psychedelic drug|psychedelic]] [[substituted amphetamine|amphetamine]]s. His contributions include the synthesis and reporting of [[escaline]], [[LSZ]], [[6-APB]], [[2C-I-NBOMe]] and other NBOMe variants ([[NBOMe-2C-B]], [[NBOMe-2C-C]], [[NBOMe-2C-D]]), and several others, as well as the coining of the term "[[entactogen]]". |
||
He is the founding president of the [[Heffter Research Institute]], named after [[Germany|German]] chemist and pharmacologist [[Arthur Heffter]], who first discovered that [[mescaline]] was the active component in the [[peyote]] cactus. In 2004 he was named the Irwin H. Page Lecturer by the former International [[Serotonin]] Club (now the International Society for Serotonin Research),{{cite web |url=https://www.serotoninclub.org/ |title=Home |website=serotoninclub.org}} and delivered an address in Portugal titled, "35 years studying psychedelics: what a long strange trip it's been". Among pharmacologists, he is considered to be one of the world's top experts on [[psychedelics]]. Nichols's other professional activities include teaching medicinal chemistry and molecular pharmacology at Purdue University in [[West Lafayette, IN]], and teaching medical students at the [[Indiana University School of Medicine]]. He officially retired in 2012 but has continued to work in the field. |
He is the founding president of the [[Heffter Research Institute]], named after [[Germany|German]] chemist and pharmacologist [[Arthur Heffter]], who first discovered that [[mescaline]] was the active component in the [[peyote]] cactus. In 2004 he was named the Irwin H. Page Lecturer by the former International [[Serotonin]] Club (now the International Society for Serotonin Research),{{cite web |url=https://www.serotoninclub.org/ |title=Home |website=serotoninclub.org}} and delivered an address in Portugal titled, "35 years studying psychedelics: what a long strange trip it's been". Among pharmacologists, he is considered to be one of the world's top experts on [[psychedelics]]. Nichols's other professional activities include teaching medicinal chemistry and molecular pharmacology at Purdue University in [[West Lafayette, IN]], and teaching medical students at the [[Indiana University School of Medicine]]. He officially retired in 2012 but has continued to work in the field. As of 2019, Nichols was an adjunct professor at the UNC Eshelman School of Pharmacy, Chapel Hill, NC.{{Cite web|url=https://pharmacy.unc.edu/news/directory/denichol/|title=David Nichols|access-date=9 February 2019|archive-date=6 September 2022|archive-url=https://web.archive.org/web/20220906133324/https://pharmacy.unc.edu/directory/denichol/|url-status=dead}} |
||
== Education == |
== Education == |
||
